SEC Form 4 · accession 0001424422-16-000021
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Craig A. Barbarosh
Director
Period of report
Jan 26, 2016
Accepted (ET)
Jan 27, 2016 · 2:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $1.55 | Jan 26, 2016 | A | 50,000 | A | Feb 29, 2016 | Jan 26, 2026 | Common stock | 50,000 | 50,000 | D |
Explanation of responses
- F1This option vests ratably over 24 months with the first vesting starting on 2/29/16.